Karen Keller and Ginnie Lynch co-author ANDA Litigation, 4th Edition, Chapter 18 on Antitrust

The 4th Edition of ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators examines the intersection between the statutory and regulatory scheme governing approval of generic pharmaceuticals and U.S. patent law, this in-depth resource balances perspectives from both name-brand drug patentees and generic drug manufacturers. With a focus on current and developing law as well as practical strategies and tactics for litigation, it covers all steps in the litigation process. Karen Keller and Ginnie Lynch worked specifically on the Antitrust Chapter.